Semler - רווח נקי למניה ב-12 החודשים האחרונים SMLR

This chart illustrating the price evolution of the stock helps assess the resilience of Semler Scientific, Inc. (SMLR) to Asian chip supply disruptions while operating in the US. The business relies on unique patent solutions and BTC holdings, which protect its market share. High brand authority in cardiology is confirmed by the success of QuantaFlo, and the current EPS stands at 63.10, highlighting the efficiency of early pathology diagnostics.

This indicator tracks the rate of change in rolling annual earnings per share, identifying capital generation efficiency relative to the previous period. For Semler Scientific, Inc. (SMLR), this mechanism reflects the monetization of its expansion into the preventive vascular diagnostics segment. By analyzing the annual EPS growth rate over the last 12 months, an investor can see the correlation between the expanding customer base and net income. A stable upward trajectory confirms the fundamental resilience of the business model.